Meckley Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth 41.42%
- Profit Growth 78.47%
- Ebitda 83.86%
- Net Worth 315.59%
- Total Assets -7.23%
About Meckley Life Sciences
Meckley Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2014 and has a history of Ten years and five months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Meckely Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.00 M.
Priya Singh, Rashmi Jaiswal, Shailaja Srivastava, and One other member serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74900MH2014PTC257552
-
Company No.
257552
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Aug 2014
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Meckley Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priya Singh
|
Director | 17-Oct-2024 | Current |
|
Rashmi Jaiswal
|
Director | 17-Oct-2024 | Current |
|
Shailaja Srivastava
|
Director | 25-Aug-2014 | Current |
|
Vikash Srivastava
|
Director | 19-Jun-2018 | Current |
Financial Performance of Meckley Life Sciences.
Meckley Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.42% increase. The company also saw a substantial improvement in profitability, with a 78.47% increase in profit. The company's net worth Soared by an impressive increase of 315.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meckley Life Sciences?
Unlock access to Meckley Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2023 | Others | ₹3.00 M | Open |
How Many Employees Work at Meckley Life Sciences?
Unlock and access historical data on people associated with Meckley Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meckley Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meckley Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
